Compare how activists are reshaping value stories like Takara Holdings by scanning our hand picked 73 high quality undiscovered gems that could be next in line for portfolio clean ups and capital shifts.
For Takara Holdings, the big picture is about whether you believe a sprawling group that sells alcohol, seasonings, and biotech products can keep earning an acceptable return on the capital tied up in all those activities. Earnings have declined by 5.1% per year over the past 5 years and net profit margins have eased to 3% from 4.5%, so operational execution and pricing power matter more than ever. The recent Oasis involvement, together with the move to transfer 70% of Takara Butsuryu System, directly targets that question of where money is best deployed.
In the short term, the key swing factors are still fairly grounded items. Can the beverage and seasoning operations sustain demand and pricing? Can the more capital intensive pieces like biotech justify their investment needs? And can management keep logistics and support units from dragging on returns? The share price has been volatile, the P/E sits at 51.5x against an Asian beverage average of 16.4x, and the stock has already risen strongly over 1 year, so activism that pushes for sharper capital allocation could be material for both risk and reward.
That said, there is a tougher question lurking behind Takara Holdings’ recent share price strength and activist spotlight that relates to...
There's only one way to know the right time to buy, sell or hold Takara Holdings. Head to Simply Wall St's company report for the latest analysis of Takara Holdings's Fair Value.
Disagree with this assessment? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
If the Takara Holdings story has you thinking about where capital could be put to work more efficiently, it can help to line it up against other businesses with different risk and balance sheet profiles using the Simply Wall St Screener.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com